Regeneron Pharmaceuticals | REGN - Себестоимость





Себестоимость Изменить Дата
AbbVie USD 4.22B 329M 2026-03
Agenus USD 642K 399K 2025-09
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Alnylam Pharmaceuticals USD 211.12M 56.6M 2026-03
Amgen USD 1.6B 187M 2026-03
Astellas Pharma JPY 129.43B 19.7B 2026-03
AstraZeneca USD -204M 3.48B 2026-03
Biogen USD 797.5M 302M 2026-03
BioMarin Pharmaceutical USD 199.48M 37.93M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Eli Lilly USD 3.58B 205M 2026-03
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Gilead Sciences USD 1.44B 174M 2026-03
GlaxoSmithKline GBP 1.88B 736M 2026-03
Incyte USD 104.5M 16.68M 2026-03
Ionis Pharmaceuticals USD 3M 5M 2026-03
J&J USD 8.07B 103M 2026-03
Kyowa Hakko Kirin JPY 33B 4.87B 2026-03
Merck USD 2.94B 380M 2026-03
Moderna USD 955M 503M 2026-03
Neurocrine Biosciences USD 13.8M 3.8M 2026-03
Novartis USD 3.46B 83M 2026-03
Novartis USD 3.54B 7M 2025-12
Pfizer USD 4.59B 1.7B 2026-03
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.76B 344M 2025-12
Sarepta Therapeutics USD 109.46M 289.93M 2026-03
Teva Pharmaceutical Industries USD 2.01B 46M 2026-03
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
United Therapeutics USD 133.4M 341.3M 2026-03
Vertex Pharmaceuticals USD 392.8M 73.2M 2026-03